Dendritic cell immunotherapy: mapping the way

被引：778

作者：

Figdor, CG

de Vries, IJM

Lesterhuis, WJ

Melief, CJM

机构：

[1] Univ Med Ctr Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, NL-6500 HB Nijmegen, Netherlands

[2] Univ Med Ctr Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Med Oncol, NL-6500 HB Nijmegen, Netherlands

[3] Univ Med Ctr Leiden, Dept Immunohematol & Blood Transfus, NL-2300 RA Leiden, Netherlands

来源：

NATURE MEDICINE | 2004年 / 10卷 / 05期

关键词：

D O I：

10.1038/nm1039

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Dendritic cells (DCs) are the professional antigen-presenting cells of the immune system, with the potential to either stimulate or inhibit immune responses. Exploiting the immune-regulatory capacities of dendritic cells holds great promise for the treatment of cancer, autoimmune diseases and the prevention of transplant rejection. Although early clinical trials indicate that DC vaccines can induce immune responses in some cancer patients, careful study design and use of standardized clinical and immunological criteria are needed.

引用

页码：475 / 480

页数：6

共 50 条

[11] de Vries IJM, 2003, CLIN CANCER RES, V9, P5091
[12] Mature dendritic cells boost functionally superior CD8+ T-cell without foreign helper epitopes
Dhodapkar, MV
Krasovsky, J
Steinman, RM
Bhardwaj, N
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (06) : R9 - R14
[13] Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
Dhodapkar, MV
Steinman, RM
Sapp, M
Desai, H
Fossella, C
Krasovsky, J
Donahoe, SM
Dunbar, PR
Cerundolo, V
Nixon, DF
Bhardwaj, N
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) : 173 - 180
[14] Immune escape through C-type lectins on dendritic cells
Engering, A
Geijtenbeek, TBH
van Kooyk, Y
[J]. TRENDS IN IMMUNOLOGY, 2002, 23 (10) : 480 - 485
[15] INTERLEUKIN-2 PRODUCTION BY TUMOR-CELLS BYPASSES T-HELPER FUNCTION IN THE GENERATION OF AN ANTITUMOR RESPONSE
FEARON, ER
PARDOLL, DM
ITAYA, T
GOLUMBEK, P
LEVITSKY, HI
SIMONS, JW
KARASUYAMA, H
VOGELSTEIN, B
FROST, P
[J]. CELL, 1990, 60 (03) : 397 - 403
[16] Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein
Fujii, S
Shimizu, K
Smith, C
Bonifaz, L
Steinman, RM
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (02) : 267 - 279
[17] Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo
Garg, S
Oran, A
Wajchman, J
Sasaki, S
Maris, CH
Kapp, JA
Jacob, J
[J]. NATURE IMMUNOLOGY, 2003, 4 (09) : 907 - 912
[18] Geiger JD, 2001, CANCER RES, V61, P8513
[19] Immunotherapy of cancer with dendritic-cell-based vaccines
Gilboa, E
Nair, SK
Lyerly, HK
[J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 46 (02) : 82 - 87
[20] Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors
Heiser, A
Coleman, D
Dannull, J
Yancey, D
Maurice, MA
Lallas, CD
Dahm, P
Niedzwiecki, D
Gilboa, E
Vieweg, J
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (03) : 409 - 417

← 1 2 3 4 5 →